Hyaluronan deposition in islets may precede and direct the location of islet immune-cell infiltrates.


Journal

Diabetologia
ISSN: 1432-0428
Titre abrégé: Diabetologia
Pays: Germany
ID NLM: 0006777

Informations de publication

Date de publication:
03 2020
Historique:
received: 18 04 2019
accepted: 10 10 2019
pubmed: 8 1 2020
medline: 2 4 2021
entrez: 8 1 2020
Statut: ppublish

Résumé

Substantial deposition of the extracellular matrix component hyaluronan (HA) is characteristic of insulitis in overt type 1 diabetes. We investigated whether HA accumulation is detectable in islets early in disease pathogenesis and how this affects the development of insulitis and beta cell mass. Pancreas tissue from 15 non-diabetic organ donors who were positive for islet autoantibodies (aAbs) and from 14 similarly aged aAb Abundant islet HA deposits were observed in pancreas tissues from n = 3 single- and n = 4 double-aAb This study indicates that HA deposition in islets occurs early in type 1 diabetes and prior to insulitis, and points to a potential role of HA in triggering islet immune-cell infiltration and the promotion of insulitis.

Identifiants

pubmed: 31907557
doi: 10.1007/s00125-019-05066-7
pii: 10.1007/s00125-019-05066-7
pmc: PMC7002022
mid: NIHMS1548329
doi:

Substances chimiques

Autoantibodies 0
Insulin 0
Hyaluronic Acid 9004-61-9

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

549-560

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK017047
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI101990
Pays : United States
Organisme : Helmsley Charitable Trust George S. Eisenbarth nPOD Award for Team Science
ID : 2015PG T1D052
Pays : International

Références

Diabetologia. 2016 Mar;59(3):542-9
pubmed: 26676824
J Exp Med. 2012 Jan 16;209(1):51-60
pubmed: 22213807
Diabetologia. 2018 Dec;61(12):2499-2506
pubmed: 30255378
Methods Mol Biol. 2001;171:479-85
pubmed: 11450261
Diabetes. 2016 Aug;65(8):2105-14
pubmed: 27456615
Immunol Cell Biol. 1996 Apr;74(2):A1-7
pubmed: 8724014
Diabetologia. 2013 Nov;56(11):2541-3
pubmed: 24006089
Immunol Res. 2005;31(3):189-206
pubmed: 15888911
Acta Pathol Microbiol Scand. 1961;53:230-6
pubmed: 13906265
J Endocrinol. 2013 Jan 18;216(2):111-23
pubmed: 23111281
Matrix Biol. 2012 Mar;31(2):90-100
pubmed: 22155153
Diabetes. 2014 Aug;63(8):2727-43
pubmed: 24677718
JAMA. 2013 Jun 19;309(23):2473-9
pubmed: 23780460
Diabetes Metab Rev. 1992 Oct;8(3):209-27
pubmed: 1292912
N Engl J Med. 1986 May 22;314(21):1360-8
pubmed: 3517648
Islets. 2009 Sep-Oct;1(2):129-36
pubmed: 20606719
Lancet. 2014 Jan 4;383(9911):69-82
pubmed: 23890997
ILAR J. 2004;45(3):278-91
pubmed: 15229375
J Biol Chem. 2009 Feb 20;284(8):5299-312
pubmed: 19088077
Diabetologia. 2003 Mar;46(3):305-21
pubmed: 12687328
Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18425-30
pubmed: 16339897
Front Immunol. 2014 Mar 11;5:101
pubmed: 24653726
J Biol Chem. 1999 Oct 22;274(43):30747-55
pubmed: 10521464
Physiol Rev. 2011 Jan;91(1):221-64
pubmed: 21248167
Diabetologia. 2001 Dec;44(12):2115-33
pubmed: 11793013
Diabetes. 1997 Nov;46(11):1701-10
pubmed: 9356015
FEBS J. 2011 May;278(9):1412-8
pubmed: 21362136
Diabetes Care. 2018 Sep;41(9):1887-1894
pubmed: 30002199
Pediatr Diabetes. 2018 Oct;19 Suppl 27:20-27
pubmed: 30051639
Expert Rev Clin Immunol. 2013 Dec;9(12):1173-83
pubmed: 24215407
Endocrinology. 1997 Jun;138(6):2610-4
pubmed: 9165055
Diabetes. 1965 Oct;14(10):619-33
pubmed: 5318831
N Engl J Med. 2009 Apr 16;360(16):1646-54
pubmed: 19369670
Islets. 2011 Jul-Aug;3(4):131-8
pubmed: 21606672
Cold Spring Harb Perspect Med. 2012 Jan;2(1):a007732
pubmed: 22315720
Clin Transl Sci. 2008 May;1(1):57-61
pubmed: 20443819
Physiol Genomics. 2009 Jun 10;38(1):89-97
pubmed: 19351909
Diabetes. 2016 Mar;65(3):719-31
pubmed: 26581594
Diabetes Care. 2015 Oct;38(10):1975-85
pubmed: 26404927
Diabetes Care. 2015 Oct;38(10):1964-74
pubmed: 26404926
Immunity. 2010 Apr 23;32(4):468-78
pubmed: 20412757

Auteurs

Marika Bogdani (M)

Matrix Biology Program, Benaroya Research Institute at Virginia Mason, 1201 9th Avenue, Seattle, WA, 98101, USA. mbogdani@benaroyaresearch.org.

Cate Speake (C)

Diabetes Research Program and Clinical Research Center, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA.

Mathew J Dufort (MJ)

Bioinformatics Department, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA.

Pamela Y Johnson (PY)

Matrix Biology Program, Benaroya Research Institute at Virginia Mason, 1201 9th Avenue, Seattle, WA, 98101, USA.

Megan J Larmore (MJ)

Histology and Imaging Core, University of Washington, Seattle, WA, USA.

Anthony J Day (AJ)

Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester, UK.

Thomas N Wight (TN)

Matrix Biology Program, Benaroya Research Institute at Virginia Mason, 1201 9th Avenue, Seattle, WA, 98101, USA.

Åke Lernmark (Å)

Department of Medicine, University of Washington, Seattle, WA, USA.
Department of Clinical Sciences, Lund University/CRC, Skåne University Hospital, Malmö, Sweden.

Carla J Greenbaum (CJ)

Diabetes Research Program and Clinical Research Center, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH